Clinical Trials Update: Feb. 15, 2008
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
256558
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday that it was halting the use of the painkiller Celebrex in a clinical trial on colorectal cancer patients after a study found an apparent increase in the risk of heart attack among those taking the drug.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.
17491
A report to be released on Friday  finds the U.S. Food and Drug Administration does very little to  ensure the safety of patients who help test drugs in clinical  trials, The New York Times reports.
704575
NEW YORK -- A new study has linked painkillers Vioxx, Celebrex, and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs.
402115
Two drugs provide good results in preliminary trials.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
92836
THURSDAY, Aug. 19 (HealthDayNews) -- A new screening technique to search for genes that change patients' response to cancer drugs and other medications has been developed by scientists at Washington University Medical Center.
438501
Here's what a newly approved drug looks like.
90104
A report to be released on Friday finds the U.S. Food and Drug Administration does very little to ensure the safety of patients who help test drugs in clinical trials, The New York Times reports.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...
535175
BioSante releases more info on the pivotal studies for its lead drug.